Cargando…

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials

BACKGROUND: We previously reported that vaccination with the tetravalent dengue vaccine (CYD-TDV; Dengvaxia) may bias the diagnosis of dengue based on immunoglobulin M (IgM) and immunoglobulin G (IgG) assessments. METHODS: We undertook a post hoc pooled analysis of febrile episodes that occurred dur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plennevaux, Eric, Moureau, Annick, Arredondo-García, José L, Villar, Luis, Pitisuttithum, Punnee, Tran, Ngoc H, Bonaparte, Matthew, Chansinghakul, Danaya, Coronel, Diana L, L’Azou, Maïna, Ochiai, R Leon, Toh, Myew-Ling, Noriega, Fernando, Bouckenooghe, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888923/ https://www.ncbi.nlm.nih.gov/pubmed/29300876 http://dx.doi.org/10.1093/cid/cix966

Ejemplares similares

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)
por: L’Azou, Maïna, et al.
Publicado: (2018)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
por: Vigne, Claire, et al.
Publicado: (2017)

Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries
por: Nealon, Joshua, et al.
Publicado: (2019)

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial
por: Nealon, Joshua, et al.
Publicado: (2016)

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
por: Forrat, Rémi, et al.
Publicado: (2021)

Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review
por: Limkittikul, Kriengsak, et al.
Publicado: (2014)

Epidemiology of Dengue Disease in Malaysia (2000–2012): A Systematic Literature Review
por: Mohd-Zaki, Abdul Hamid, et al.
Publicado: (2014)

Reviewing the Literature for Epidemiological Trends of Dengue Disease: Introduction to a Series of Seven National Systematic Literature Reviews
por: L'Azou, Maïna, et al.
Publicado: (2014)

Recent Epidemiological Trends of Dengue in the French Territories of the Americas (2000–2012): A Systematic Literature Review
por: L'Azou, Maïna, et al.
Publicado: (2014)

Epidemiology of Dengue Disease in the Philippines (2000–2011): A Systematic Literature Review
por: Bravo, Lulu, et al.
Publicado: (2014)

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease
por: Pasin, Chloé, et al.
Publicado: (2018)

Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine
por: El Fezzazi, Hanna, et al.
Publicado: (2017)

Dengue: etiology of acute febrile illness in Abidjan, Côte d'Ivoire, in 2011–2012
por: L'Azou, Maïna, et al.
Publicado: (2015)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
por: Tran, Ngoc Huu, et al.
Publicado: (2019)

Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America
por: Zambrano, Betzana, et al.
Publicado: (2021)

Dengue Seroprevalence in the French West Indies: A Prospective Study in Adult Blood Donors
por: L'Azou, Maïna, et al.
Publicado: (2015)

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
por: Thomas, Rasmi, et al.
Publicado: (2022)

Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database
por: Uhart, M., et al.
Publicado: (2015)

Laboratory-confirmed Dengue in Children in Three Regional Hospitals in the Philippines in 2009−2010
por: Capeding, Maria Rosario Z., et al.
Publicado: (2015)

Antimicrobial Stewardship in Tropical Infectious Diseases: Focusing on Dengue and Malaria
por: Siribhadra, Ashley, et al.
Publicado: (2022)

Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand
por: Pitisuttithum, Punnee, et al.
Publicado: (2015)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals
por: DiazGranados, Carlos A, et al.
Publicado: (2020)

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9–60 Years of Age in the Philippines
por: Santos, Jaime, et al.
Publicado: (2021)

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
por: Kirstein, Judith, et al.
Publicado: (2018)

Comorbidities increase in-hospital mortality in dengue patients in Brazil
por: Werneck, Guilherme L, et al.
Publicado: (2018)

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014)

Controlling Dengue with Vaccines in Thailand
por: Chao, Dennis L., et al.
Publicado: (2012)

Vaccine development lessons between HIV and COVID-19
por: Vasan, Sandhya, et al.
Publicado: (2021)

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
por: Kamolratanakul, Supitcha, et al.
Publicado: (2021)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
por: Rabaa, Maia A, et al.
Publicado: (2017)

Dengue Vaccines: An Update
por: Torres-Flores, Jesús M., et al.
Publicado: (2022)

Safety of Dengue Vaccine?
por: Biswal, Shibadas, et al.
Publicado: (2022)

SIR Model for Dengue Disease with Effect of Dengue Vaccination
por: Chanprasopchai, Pratchaya, et al.
Publicado: (2018)

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development
por: Timiryasova, Tatyana M., et al.
Publicado: (2013)

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9–13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study
por: Hassan, Jamiyah, et al.
Publicado: (2021)

Call to Action for Dengue Vaccine Failure
por: Mahalingam, Suresh, et al.
Publicado: (2013)

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series
por: Park, Juliana, et al.
Publicado: (2019)

Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children
por: Capeding, Maria Rosario, et al.
Publicado: (2013)

Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area
por: Limothai, Umaporn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eg4k8idiottjg050kmeg2ha716